Full video transcriptClick to expand
Auto-generated transcript of @realalejandroreyes's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Gear or peptides, which one do we take?
- 0:01If you ain't a little bitch, you take both.
- 0:03But if you're too scared of last gear, I get it.
- 0:06Peptides is the way to go.
- 0:07And all it is is to break down on amino acids.
- 0:09Natural, doesn't take away your nanny card.
- 0:11You got to say, unless you're trying to do
- 0:13a natural body building show, very different.
- 0:15They test for peptides.
- 0:17But if you're just a regular-ass dude,
- 0:19and you want to look in the field
- 0:20and you're too scared of last gear,
- 0:21hit on the peptides, bro.
- 0:23You want to put on size and muscle, IGF-1.
- 0:24You want to get shredded, you can kick your all word.
- 0:26You want to lose that visceral fat
- 0:27or the lower belly fat, test them all in.
- 0:30You want something to get you hungry or GH-R-B6.
- 0:32You want something to make you tanner, melano tanner.
- 0:34You want something to help your skin
- 0:35with your fucking acne, GHK-C-U.
- 0:37You're losing hair, GHK-C-U.
- 0:39Like bro, like if you have a problem or an issue,
- 0:43peptides is the way to go.
- 0:44There's so many different peptides
- 0:46to help you with anything you're going through in life.
- 0:48You're fat as fuck, blast the all word, my G.
- 0:51You know what I'm saying?
- 0:53It's just that simple.
- 0:54But if you're a real-ass dude,
- 0:56you get off peptides and some gear,
- 0:57then you look jack and handsome.
Peptide therapy TikTok claims: what the science actually supports
Quick answer
This video promotes unsupervised self-administration of multiple peptides including IGF-1, tesamorelin, GHRP-6, GHK-Cu, and AOD-9604 for body composition goals. None of these compounds are FDA-approved for the uses described here, and AOD-9604 specifically failed phase 3 trials for obesity. Tesamorelin's visceral fat reduction data applies to a specific clinical population, HIV-associated lipodystrophy, not the general population context implied in the video.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptide therapy TikTok claims: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
EGRIFTA (tesamorelin for injection) FDA Prescribing Information
FDA-approved label for tesamorelin (NDA 022505), indicated to reduce excess abdominal fat in HIV patients with lipodystrophy.
FDA
Egrifta (tesamorelin) Original NDA 022505 FDA Approval Letter
FDA approval letter marking the first approved drug for HIV-associated lipodystrophy.
FDA
Effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism in obese and beta3-AR knockout mice
Mouse study; AOD9604 affected fat metabolism in mice, but the subsequent human obesity efficacy trial reported no meaningful weight loss versus placebo.
PubMed
Increase of fat oxidation and weight loss in obese mice by a modified C-terminal GH fragment
Obese-mouse study of the AOD9604 fragment; preclinical only, and these effects were not reproduced in human obesity trials.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Peptide therapy TikTok claims: what the science actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptide therapy TikTok claims: what the science actually supports" from realalejandroreyes. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video promotes unsupervised self-administration of multiple peptides including IGF-1, tesamorelin, GHRP-6, GHK-Cu, and AOD-9604 for body composition goals.
The reason this review is not generic is the source wording and the canonical claim label "peptides dm me if you have questions." In this clip, the useful excerpt is: "Gear or peptides, which one do we take?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against EGRIFTA (tesamorelin for injection) FDA Prescribing Information (2024), Egrifta (tesamorelin) Original NDA 022505 FDA Approval Letter (2010), and Effects of tesamorelin in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial (2010), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
This video promotes unsupervised self-administration of multiple peptides including IGF-1, tesamorelin, GHRP-6, GHK-Cu, and AOD-9604 for body composition goals.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- This video promotes unsupervised self-administration of multiple peptides including IGF-1, tesamorelin, GHRP-6, GHK-Cu, and AOD-9604 for body composition goals. None of these compounds are FDA-approved for the uses described here, and AOD-9604 specifically failed phase 3 trials for obesity. Tesamorelin's visceral fat reduction data applies to a specific clinical population, HIV-associated lipodystrophy, not the general population context implied in the video.
- AOD-9604 failed phase 3 clinical trials for obesity. It is not a proven fat-loss agent despite frequent promotion in fitness communities.
- Tesamorelin reduces visceral fat in clinical studies, but those studies were conducted in adults with HIV-associated lipodystrophy, not healthy individuals trying to lose belly fat.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- AOD-9604 failed phase 3 clinical trials for obesity. It is not a proven fat-loss agent despite frequent promotion in fitness communities.
- Tesamorelin reduces visceral fat in clinical studies, but those studies were conducted in adults with HIV-associated lipodystrophy, not healthy individuals trying to lose belly fat.
- GHK-Cu has legitimate published research on skin remodeling (Pickart and Margolina, 2018), but hair loss claims rely mostly on preclinical data.
- IGF-1 carries documented risks including hypoglycemia and concerns around tumor promotion flagged in peer-reviewed oncology literature, risks absent from this video.
- WADA prohibits GHRP-6, IGF-1, and other growth hormone secretagogues. The creator's note that natural bodybuilding federations test for peptides is factually correct.
- The FDA issued warnings in 2023 about compounded peptide products citing sterility and dosing accuracy concerns, a real risk for anyone sourcing these compounds outside a regulated pharmacy.
- No peptide discussed in this video is FDA-approved for the body composition uses described. Legitimate peptide therapy requires physician evaluation and individualized oversight.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @realalejandroreyes actually say?
The short version: peptides are natural, safe alternatives to anabolic steroids, and there's basically one for every problem you have. The creator rattled off a list, IGF-1 for muscle, AOD-9604 (the "all word" referenced repeatedly) for fat loss, tesamorelin for visceral fat, GHRP-6 for appetite stimulation, melanotan for tanning, and GHK-Cu for skin and hair. The framing was simple: not ready for "gear" (anabolic steroids)? Peptides are your on-ramp. And if you're serious, you use both.
He also threw in a caveat that natural bodybuilding federations test for peptides, which is worth noting because it's the one moment in the video where he's technically correct about something verifiable. The rest is a mix of oversimplification, real science stretched thin, and a few claims that have no serious clinical backing at the doses and contexts he's implying.
Does the science back this up?
Partially, but not in the way this video frames it. Peptides are not a unified category of safe, consequence-free compounds. Some have legitimate clinical research behind them. Others are being sold on vibes and bro-science.
GHK-Cu has real published research. Studies by Pickart and Margolina (2018, Cosmetics) found evidence for wound healing and skin remodeling activity. Hair loss research is more limited, with mostly preclinical data. IGF-1 is a legitimate growth factor with documented anabolic effects, but exogenous IGF-1 administration is associated with hypoglycemia, joint pain, and potential tumor promotion risks flagged by researchers including Pollak (2012, Nature Reviews Cancer). Tesamorelin is FDA-approved specifically for HIV-associated lipodystrophy. It does reduce visceral fat in that population. Applying that to general "lower belly fat" in healthy people is a stretch that the clinical literature does not support without reservation. AOD-9604, described here as the go-to fat-loss peptide, failed its phase 3 clinical trials for obesity. Metabolic Pharmaceuticals discontinued development after the drug did not demonstrate statistically significant weight loss versus placebo.
What did they get wrong (or right)?
Wrong: the claim that peptides are inherently "natural" and consequence-free is misleading. Peptides are biologically active signaling molecules. "Natural" does not mean safe at pharmacological doses, and none of these compounds are FDA-approved for the uses described here.
Wrong: AOD-9604 as a fat-loss solution. This peptide failed clinical trials. Presenting it as a reliable shredding tool contradicts the published evidence.
Partly right: GHK-Cu for skin has a legitimate research base, though the hair loss application is mostly preclinical. Tesamorelin does have a documented effect on visceral fat, but only in a specific clinical population under physician supervision.
Right: natural bodybuilding federations do test for peptides, including growth hormone secretagogues. WADA prohibits GHRP-6, IGF-1, and related compounds. That's a factual statement buried in an otherwise oversold pitch.
- IGF-1: real anabolic effects, real risks including hypoglycemia and oncological concerns
- AOD-9604: failed phase 3 trials, not a proven fat-loss agent
- GHK-Cu: solid early evidence for skin, limited for hair
- Tesamorelin: FDA-approved but only for HIV lipodystrophy, not general belly fat
- GHRP-6: increases ghrelin and appetite, documented but not without side effects including cortisol and prolactin elevation
What should you actually know?
The biggest problem with this video isn't that every claim is false. It's that accurate fragments are stitched together into a framework that encourages people to self-administer research-grade peptides without any clinical oversight, based on a 90-second TikTok from someone whose credentials are not disclosed.
Peptide therapy is a legitimate and growing field. But legitimate use means physician evaluation, lab work, and individualized protocols. It does not mean DMing a creator and blasting AOD-9604 because you're "fat as fuck." Unregulated peptide sources also carry real contamination risks. A 2023 FDA warning flagged compounded peptide products for sterility and dosing concerns. None of that appears in this video.
If you're curious about peptide therapy, that's a reasonable thing to explore with a licensed clinician who can actually review your health history. What it shouldn't be is a shopping list assembled from a hype video.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
realalejandroreyes · TikTok creator
97.3K views on this video
DM me if you have questions
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about aod-9604 failed phase 3 clinical trials for obesity. it?
AOD-9604 failed phase 3 clinical trials for obesity. It is not a proven fat-loss agent despite frequent promotion in fitness communities.
What does the video say about tesamorelin reduces visceral fat in clinical studies,?
Tesamorelin reduces visceral fat in clinical studies, but those studies were conducted in adults with HIV-associated lipodystrophy, not healthy individuals trying to lose belly fat.
What does the video say about ghk-cu has legitimate published research on skin remodeling (pickart?
GHK-Cu has legitimate published research on skin remodeling (Pickart and Margolina, 2018), but hair loss claims rely mostly on preclinical data.
What does the video say about igf-1 carries documented risks including hypoglycemia?
IGF-1 carries documented risks including hypoglycemia and concerns around tumor promotion flagged in peer-reviewed oncology literature, risks absent from this video.
What does the video say about wada prohibits ghrp-6, igf-1,?
WADA prohibits GHRP-6, IGF-1, and other growth hormone secretagogues. The creator's note that natural bodybuilding federations test for peptides is factually correct.
What does the video say about the fda?
The FDA issued warnings in 2023 about compounded peptide products citing sterility and dosing accuracy concerns, a real risk for anyone sourcing these compounds outside a regulated pharmacy.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by realalejandroreyes, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.